Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses

被引：0
|
作者：
Prezotti, Alessandra N. L. [1 ,2 ]
Villaca, Paula Ribeiro [3 ]
Rocha, Debora M. C. [2 ]
Orletti, Maria P. S. V. [2 ]
Lourenco, Christiane [2 ]
Yamaguti Hayakawa, Gabriela G. [1 ,4 ]
Ozelo, Margareth C. [1 ,4 ]
机构：
[1] Univ Estadual Campinas, Sch Med Sci, Dept Internal Med, UNICAMP, Campinas, SP, Brazil
[2] HEMOES, Hemoctr Espirito Santo, Vitoria, ES, Brazil
[3] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, SP, Brazil
[4] Univ Estadual Campinas, Hemoctr UNICAMP, Campinas, SP, Brazil
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-171028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: A critical systematic review
    Franchini, Massimo
    Tagliaferri, Annarita
    Mengoli, Carlo
    Cruciani, Mario
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 81 (01) : 82 - 93
  • [2] Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review
    Iorio, A.
    Halimeh, S.
    Holzhauer, S.
    Goldenberg, N.
    Marchesini, E.
    Marcucci, M.
    Young, G.
    Bidlingmaier, C.
    Brandao, L. R.
    Ettingshausen, C. E.
    Gringeri, A.
    Kenet, G.
    Knoefler, R.
    Kreuz, W.
    Kurnik, K.
    Manner, D.
    Santagostino, E.
    Mannucci, P. M.
    Nowak-Goettl, U.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (06) : 1256 - 1265
  • [3] Plasma-derived or recombinant factor VIII products and inhibitors in previously untreated patients with severe hemophilia
    van der Bom, Johanna G.
    Gouw, Samantha C.
    van den Berg, H. Marijke
    BLOOD, 2007, 110 (03) : 1074 - 1075
  • [4] The Impact of Recombinant Versus Plasma-Derived Factor VIII Concentrates on Inhibitor Development in Previously Untreated Patients With Hemophilia A: A 2021 Update of a Systematic Review and Meta-Analysis
    Kohar, Kelvin
    Prayogo, Stephanie A.
    Wiyono, Lowilius
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [5] Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A:: the CANAL cohort study
    Gouw, Samantha C.
    van der Bom, Johanna G.
    Auerswald, Guenter
    Ettinghausen, Carmen Escuriola
    Tedgard, Ulf
    van den Berg, H. Marijke
    BLOOD, 2007, 109 (11) : 4693 - 4697
  • [6] Incidence of inhibitors in haemophilia A patients - a review of recent studies of recombinant and plasma-derived factor VIII concentrates
    Scharrer, I
    Bray, GL
    Neutzling, O
    HAEMOPHILIA, 1999, 5 (03) : 145 - 154
  • [7] Is it dangerous to treat previously untreated patients with severe hemophilia A with recombinant factor VIII concentrates?
    Drillaud, Nicolas
    Lienhart, Anne
    Babuty, Antoine
    Dargaud, Yesim
    Chamouard, Valerie
    Trossaert, Marc
    Fouassier, Marc
    Rugeri, Lucia
    Sigaud, Marianne
    Lefranc, Carole
    Ternisien, Catherine
    Meunier, Sandrine
    HAEMOPHILIA, 2020, 26 : 67 - 67
  • [8] Rates of Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A Treated with Plasma-Derived or Recombinant Factor VIII: No Proof of Difference or Proof of No Difference?
    Messori, Andrea
    Fadda, Valeria
    Maratea, Dario
    Trippoli, Sabrina
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (02): : 269 - 270
  • [9] Response to "Rates of Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A Treated with Plasma-Derived or Recombinant Factor VIII: No Proof of Difference or Proof of No Difference?"
    Franchini, Massimo
    Mengoli, Carlo
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (02): : 271 - 272
  • [10] Inhibitor development and efficacy of recombinant vs. plasma-derived factor VIII concentrates in haemophilia A patients
    Siegmund, B.
    Richter, H.
    Pollmann, H.
    Orlovic, M.
    Gottstein, S. .
    Klamroth, R.
    HAEMOPHILIA, 2008, 14 : 51 - 51
12345